Momenex 50 mikrog/dosis nasal spray

Momenex is a pharmaceutical brand specializing in nasal care, specifically containing the active ingredient mometasone furoate. The brand is part of a complex global generic supply chain. While many preparations of mometasone are manufactured in Canada by specialist facilities, actual production for the European market can occur in various certified pharmaceutical plants across the continent and beyond.

The product shown is distributed in the Danish market by 2care4, a company specializing in the parallel import and distribution of pharmaceuticals. The brand itself is part of the portfolio of the global pharmaceutical giant Sandoz. Sandoz was formerly a division of the Swiss company Novartis but spun off to become an independent entity, maintaining its headquarters in Switzerland as a global leader in generic and biosimilar medicines.